![Leigh Brody](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leigh Brody
Director/Board Member at Bloomsbury Genetic Therapies Ltd.
Leigh Brody active positions
Companies | Position | Start | End |
---|---|---|---|
Albion Capital Group LLP
![]() Albion Capital Group LLP Investment ManagersFinance Albion Ventures LLP (Albion Ventures) is a venture capital firm founded in 1996. The firm is headquartered in London. | Private Equity Investor | 31/12/2020 | - |
Bloomsbury Genetic Therapies Ltd.
![]() Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Director/Board Member | 31/03/2022 | - |
Career history of Leigh Brody
Training of Leigh Brody
Imperial College London | Doctorate Degree |
Simmons University | Undergraduate Degree |
Statistics
International
United Kingdom | 4 |
United States | 2 |
Operational
Private Equity Investor | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Albion Capital Group LLP
![]() Albion Capital Group LLP Investment ManagersFinance Albion Ventures LLP (Albion Ventures) is a venture capital firm founded in 1996. The firm is headquartered in London. | Finance |
Bloomsbury Genetic Therapies Ltd.
![]() Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Health Technology |
- Stock Market
- Insiders
- Leigh Brody
- Experience